The PDCD10 gene helps keep small blood vessels stable and well organized, especially in the brain. The protein made by this gene helps your cells maintain the structure and signals that vessel walls need. If this gene does not work properly, some people develop cerebral cavernous malformations, which are clusters of fragile blood vessels that can bleed. This can lead to headaches, seizures, or stroke-like symptoms, and inherited pathogenic variants in the PDCD10 gene are a known cause of one familial form of this condition.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the instructions for producing proteins, which are the working parts of cells. Other genes mostly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can find more in LearnHub.
Overview
PDCD10Gene function
What if the gene works
Your cells use the PDCD10 gene to help build and maintain stable blood vessels. It also supports cell signaling, growth, and survival, especially in tissues where vessel structure and repair need tight control.
Risk
What if the gene does not work
Pathogenic variants in the PDCD10 gene cause cerebral cavernous malformations, clusters of fragile blood vessels in the brain or spinal cord. Milder and more severe variants can affect how early they appear and how often bleeding, seizures, or headaches occur.
Treatment
What does that mean for your treatment
No PDCD10-specific treatment or management approach is currently established in clinical guidelines. The PDCD10 gene is being studied in cerebral cavernous malformation biology as a possible treatment target, but this has not yet changed routine drug choices or care.
Conditions associated with PDCD10
Gene function
What if the gene works
The PDCD10 gene helps cells stay organized and supports the health of blood vessel walls. A key PDCD10 gene function in blood vessel cells is helping the vessel lining stay connected and well ordered. Its protein also helps guide cell signals and the internal framework that lets cells keep their shape and position.
The PDCD10 gene helps the cells lining blood vessels stay connected and arranged in a smooth layer. This supports steady vessel structure and controlled growth as new vessels form.
Its protein helps pass along signals that tell cells when to grow, move, or settle down. This keeps routine cell behavior more coordinated, especially in blood vessel cells.
The PDCD10 gene supports the cell’s internal framework, which acts like a scaffold for shape and positioning. This helps cells keep their structure and place key cell parts where they are needed.
What is a variant?
A variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant can more substantially affect how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many PDCD10 gene variants reduce the amount of usable PDCD10 protein or alter its shape, which can weaken protein stability and disrupt key protein interactions inside cells. In practice, this is how PDCD10 gene variants affect protein function. Milder variants may leave some activity, while more severe loss-of-function variants often lead to little or no usable protein. In cerebral cavernous malformations, that difference can influence how early changes appear and how extensive they become.
How variants are linked to conditions
Pathogenic variants in the PDCD10 gene cause cerebral cavernous malformation type 3, an inherited condition that can lead to clusters of fragile blood vessels in the brain and spinal cord. People with this diagnosis may have seizures, headaches, bleeding in the brain, or stroke-like symptoms, while some remain symptom free for years. In many families, PDCD10 gene variants linked to cerebral cavernous malformations are associated with younger onset and more lesions than some other CCM genes.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PDCD10, risk is driven mainly by whether you carry a disease-causing variant, often inherited in a family. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower this genetic risk, so care usually focuses on monitoring and early treatment if brain or spinal blood vessel changes appear.
Inheritance of PDCD10 variants
PDCD10-related cerebral cavernous malformation usually follows an autosomal dominant inheritance pattern. This means a parent with a disease-causing variant in the PDCD10 gene can pass it to a child, with a 50% chance in each pregnancy. In practical terms, how PDCD10 variants are inherited does not depend on whether the child is male or female, because the PDCD10 gene is on chromosome 3, not a sex chromosome. Some people who inherit the variant develop signs of the condition, while others may have few or no symptoms.
What does my PDCD10 result mean for my family?
A harmful change in the PDCD10 gene is linked to a family pattern where close relatives can also carry the same change. This means parents, brothers, sisters, and children may also want to learn whether they have it. Not everyone in a family will have the same symptoms, and some may have no symptoms at all even if they carry the change.
Genetic information
Genetic testing
How you find out about variants
PDCD10 genetic testing looks for variants in a blood or saliva sample, often as part of a cerebral cavernous malformation panel or broader sequencing test. The lab reads the PDCD10 gene and compares it with the usual sequence to identify variants that may help confirm a diagnosis or clarify family risk.
When should I consider getting a genetic test?
Consider genetic testing for the PDCD10 gene if you or close relatives have cavernous malformations—small clusters of abnormal blood vessels in the brain or spinal cord—especially if there are several of them, seizures, bleeding, bad headaches, or stroke-like symptoms. Testing can also make sense when a family member already has a PDCD10 variant.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it shows depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics focuses on how genetic differences can shape a person’s response to medications. It studies the link between genes and drugs to help explain why the same treatment may work differently in different people. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the PDCD10 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
PDCD10 first came to researchers’ attention in the early 2000s during studies of cell death, which is why it was named the PDCD10 gene. Soon after, scientists discovered that variants in the PDCD10 gene could cause some familial cases of cerebral cavernous malformation, a condition involving clusters of fragile blood vessels in the brain and spinal cord. From these first observations, research expanded steadily. This finding was important because it identified a third major gene behind this condition, alongside KRIT1 and CCM2. The PDCD10 gene is also commonly called CCM3 in medical papers, reflecting that historical link. Over time, descriptions became more precise, and PDCD10 became a well established part of the story of inherited cerebral cavernous malformation.